Prostate enlargement, which is called Benign Prostatic Hyperplasia (BPH) is a non-cancerous enlargement and is common in ...
MINNEAPOLIS, March 5, 2026 /PRNewswire/ — Francis Medical, Inc., a privately held medical device company, announced today the successful completion of the first commercial (non-clinical trial) ...
Vanquish uses ultrasound, transurethral and electromagnetically guided thermotherapy to ablate prostate tissue.
Hundreds of cancer patients in the region are to benefit from a new surgical robot thanks to a £1.45m donation from Sheffield Hospitals Charity, the largest ever single donation from the charity.
THOMASVILLE — Archbold Urology is committed to offering patients in the region access to the most advanced treatments for urologic conditions that affect many of its neighbors.
Punjab government is setting up a Cryoablation cancer treatment facility at Rawalpindi's Holy Family Hospital, following its introduction in Lahore. The advanced technology, sourced from China, offers ...
A senior doctor tells Dawn that cancer patients had been asked to go to private clinics and hospitals as the government ...
Metastatic prostate cancer is currently associated with high morbidity and mortality rates. In addition, patients respond very differently to standard treatments such as hormone therapy or radiation ...
Research team at OncoRay identifies MMP11 as a promising biomarker for liquid biopsy in prostate cancer Metastatic prostate cancer is currently associated with high morbidity and mortality rates. In ...
Men suffering from the disruptive symptoms of an enlarged prostate now have a new treatment option available at East Georgia Regional Medical Center. The hospital has introduced a state-of-the-art, ...
One by one, the surgical robots are marching into Tucson, now working at three hospitals, taking over the job of a surgeon's skilled hands. As they do, Tucson gradually is joining what may be one of ...
Clinically known as benign prostatic hyperplasia (BPH), enlarged prostate is a non‑cancerous condition that affects roughly half of men ages 51 to 60, with incidence increasing ...